Skip to content

Homeopathic medicines for problems related to incomplete and unsatisfactory bowel movement

A Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy of Individualized Homeopathic Medicines in Irritable Bowel Syndrome using Homeopathic Repertory

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/10/021632
Enrollment
60
Registered
2019-10-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K599- Functional intestinal disorder, unspecified

Interventions

Intervention1: Individualized homeopathic medicines in centesimal potencies and in individualized dosage: Individualized homeopathic medicines in centesimal potencies, as decided appropriate to the ca
dosage and repetition depending upon the individual requirement of the cases. All medicines will be procured from a Good Manufacturing Practice (GMP)-certified firm. The patients will be advised to av
dosage and repetition depending upon the individual requirement of the cases. The patients will be advised to avoid foods which trigger the disease condition like fat diet, cabbage, beans and legumes,

Sponsors

Mahesh Bhattacharyya Homoeopathic Medical College Hospital Govt of West Bengal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a) Patients suffering from IBS b) Both sexes c) Age 18-65 years d) Literate patients with ability to read Bengali and/or English e) Patients willing to participate in the study and giving written informed consent.

Exclusion criteria

Exclusion criteria: a) Patients who are too unwell to take part b) Inability to read patient information sheets and/or denied consent to take part c) Diagnosed cases of unstable psychiatric complaints or other systemic diseases affecting quality of life d) Any major gastro-intestinal surgery in last 6 months e) Currently receiving standard therapy for IBS and/or homoeopathic treatment for any chronic condition(s) f) Pregnant and lactating women g) Self-reported immune compromised conditions h) Substance abuse and/or dependence

Design outcomes

Primary

MeasureTime frame
IBS Quality of Life (IBS-QOL) questionnaire total score and eight subscale scoresTimepoint: At baseline, every month, up to 3 months

Secondary

MeasureTime frame
EQ-5D-5L questionnaire score and EQ-5D-5L VAS scoreTimepoint: At baseline, every month, up to 3 months;IBS Symptoms Severity Score (IBS-SSS)Timepoint: At baseline, every month, up to 3 months

Countries

India

Contacts

Public ContactShubhamoy Ghosh

Mahesh Bhattacharyya Homoeopathic Medical College and Hospital, Govt. of West Bengal

shubhamoy67@gmail.com9831034229

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 13, 2026